3 ms·
Doesn't matter as much, now that there are other vaccines on the market. Any new vaccine candidates will be compared against the existing ones as a golden stand
by akiselev 5y ago
Doesn't matter as much, now that there are other vaccines on the market. Any new vaccine candidates will be compared against the existing ones as a golden standard and any candidate that doesn't improve on the existing options significantly along some dimension is not likely to get approved.
The desperate scramble to reopen the world led to record development and approval times BY A FREAKING MILE. HN discourages caps but it's hard to overstate just how unprecedented these approvals were. The top 10 list of fastest drug approvals is just a list of chemotherapy drugs and the median time for novel vaccine discovery lies somewhere between decades and centuries. Now that the world is returning to normal, the standards for premarketing approval are too.
- tinus_hn 5y agoIt matters a lot because for the ‘gold standard’ existing ones the scare story is they aren’t effective against the variants either.
- tchalla 5y ago> Any new vaccine candidates will be compared against the existing ones as a golden standard But, this clinical trial didn't compare to existing ones.
- scraptor 5y agoThe results of the trial will be, just like we are doing right now